Telephone
64.9.574.0100
Address
East Tamaki 15 Maurice Paykel Place Auckland 2013
Description
Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 18.58 - 26.08
Trade Value (12mth)
AU$2,546,188.00
1 week
-3.33%
1 month
6.55%
YTD
0.61%
1 year
-6.53%
All time high
34.92
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
585m
HALO Sector
Healthcare
Next Company Report Date
21-May-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.77
Date | Announcements |
---|---|
31 March 08 |
Presentation to UBS Growth Conference, Auckland
×
Presentation to UBS Growth Conference, Auckland |
31 July 12 |
FPH 2012 Notice of Annual Meeting and Proxy Form
×
FPH 2012 Notice of Annual Meeting and Proxy Form |
31 July 12 |
FPH Notice of Annual Shareholders Meeting 2012
×
FPH Notice of Annual Shareholders Meeting 2012 |
31 July 12 |
FPH 2012 Annual Meeting Proxy Form
×
FPH 2012 Annual Meeting Proxy Form |
30 October 23 |
Application for quotation of securities - FPH
×
Application for quotation of securities - FPH |
30 October 23 |
Application for quotation of securities - FPH
×
Application for quotation of securities - FPH |
30 October 23 |
Disclosure Document
×
Disclosure Document |
30 November 15 |
FPH Presentation to Analysts and Fund Managers
×
FPH Presentation to Analysts and Fund Managers |
30 May 22 |
Cather Simpson appointed to Fisher & Paykel Healthcare Board
×
Cather Simpson appointed to Fisher & Paykel Healthcare Board |
30 May 22 |
FPH Announces New Future Director Appointment
×
FPH Announces New Future Director Appointment |
30 March 23 |
Notification of cessation of securities - FPH
×
Notification of cessation of securities - FPH |
30 March 23 |
Application for quotation of securities - FPH
×
Application for quotation of securities - FPH |
30 August 22 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
30 August 22 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
29 September 23 |
Ongoing Disclosure Notices - Options & Ordinary Shares
×
Ongoing Disclosure Notices - Options & Ordinary Shares |
29 November 23 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
29 November 23 |
Dividend/Distribution - FPH
×
Dividend/Distribution - FPH |
29 November 22 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
29 November 22 |
Dividend/Distribution - FPH
×
Dividend/Distribution - FPH |
29 November 22 |
Dividend Reinvestment Plan
×
Dividend Reinvestment Plan |
29 May 06 |
FY06 Presentation to Analysts/Fund Managers
×
FY06 Presentation to Analysts/Fund Managers |
29 June 10 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 June 07 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
29 June 07 |
Annual Report
×
Annual Report |
29 August 23 |
FPH provides guidance for first half of FY24
×
FPH provides guidance for first half of FY24 |
29 August 23 |
2023 Annual Shareholders Meeting Speeches and Presentation
×
2023 Annual Shareholders Meeting Speeches and Presentation |
29 August 23 |
2023 Annual Shareholders' Meeting Results
×
2023 Annual Shareholders' Meeting Results |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.